Autoimmune Dysautonomia Evaluation
Identification of autoimmune dysautonomia can result in early diagnosis of an associated cancer, and reversibility of symptoms with immunotherapy. Dr. Andrew McKeon will review the diagnostic testing algorithm for autoimmune dysautonomia, define the clinical aspects, and describe interpretation of laboratory testing.
- Andrew McKeon, MB, BCh, MD, consultant in the Neuroimmunology Laboratory in the Division of Clinical Biochemistry and Immunology at Mayo Clinic
Forward to a Colleague
Share this presentation with:
If you have questions, e-mail .